1. Home
  2. KRYS vs STNE Comparison

KRYS vs STNE Comparison

Compare KRYS & STNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • STNE
  • Stock Information
  • Founded
  • KRYS 2015
  • STNE 2012
  • Country
  • KRYS United States
  • STNE Cayman Islands
  • Employees
  • KRYS N/A
  • STNE N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • STNE EDP Services
  • Sector
  • KRYS Health Care
  • STNE Technology
  • Exchange
  • KRYS Nasdaq
  • STNE Nasdaq
  • Market Cap
  • KRYS 4.3B
  • STNE 4.0B
  • IPO Year
  • KRYS 2017
  • STNE 2018
  • Fundamental
  • Price
  • KRYS $144.86
  • STNE $18.11
  • Analyst Decision
  • KRYS Strong Buy
  • STNE Buy
  • Analyst Count
  • KRYS 10
  • STNE 8
  • Target Price
  • KRYS $204.90
  • STNE $16.56
  • AVG Volume (30 Days)
  • KRYS 268.2K
  • STNE 4.5M
  • Earning Date
  • KRYS 11-03-2025
  • STNE 11-11-2025
  • Dividend Yield
  • KRYS N/A
  • STNE N/A
  • EPS Growth
  • KRYS 36.22
  • STNE N/A
  • EPS
  • KRYS 4.91
  • STNE N/A
  • Revenue
  • KRYS $359,205,000.00
  • STNE $2,526,103,178.00
  • Revenue This Year
  • KRYS $34.33
  • STNE $21.73
  • Revenue Next Year
  • KRYS $47.84
  • STNE $6.95
  • P/E Ratio
  • KRYS $29.46
  • STNE N/A
  • Revenue Growth
  • KRYS 116.08
  • STNE 19.78
  • 52 Week Low
  • KRYS $122.80
  • STNE $7.72
  • 52 Week High
  • KRYS $207.84
  • STNE $18.27
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 48.61
  • STNE 74.58
  • Support Level
  • KRYS $136.73
  • STNE $15.96
  • Resistance Level
  • KRYS $152.96
  • STNE $18.15
  • Average True Range (ATR)
  • KRYS 4.68
  • STNE 0.52
  • MACD
  • KRYS -0.69
  • STNE 0.17
  • Stochastic Oscillator
  • KRYS 50.09
  • STNE 93.79

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About STNE StoneCo Ltd.

StoneCo Ltd is a provider of financial technology solutions. It serves MSMBs solutions, at fair prices, and provides the customer experience to help them manage their businesses and sell more. Its Stone Business Model combines end-to-end, cloud-based technology platforms; differentiated hyper-local and integrated distribution approaches; and white-glove, on-demand customer service. It has two segments Financial Services segment, which includes payments solutions, digital banking, credit, insurance solutions as well as the registry business. In the Software segment solution includes POS/ERP, TEF and QR Code gateways, reconciliation, CRM, OMS, e-commerce platform, engagement tool, ads solution, and marketplace hub. It generates the majority of its revenue from the Financial Services segment.

Share on Social Networks: